Detalhe da pesquisa
1.
Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice.
Acta Oncol
; 63: 277-287, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711384
2.
Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials.
Acta Oncol
; 57(1): 135-140, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168407
3.
Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG).
Acta Oncol
; 57(1): 31-37, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168427
4.
Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
Breast Cancer Res Treat
; 154(3): 483-94, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26585578
5.
Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer.
Acta Oncol
; 54(4): 530-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25383449
6.
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.
Breast Cancer
; 27(2): 266-276, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654283
7.
Patients' experience of communication and handling of symptomatic adverse events in breast cancer patients receiving adjuvant chemotherapy.
Res Involv Engagem
; 5: 36, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832240
8.
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.
Breast Cancer Res Treat
; 112(2): 275-85, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18157633
9.
Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.
PLoS One
; 13(1): e0189887, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29293529
10.
Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer.
Mol Oncol
; 12(6): 925-935, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29689598
11.
PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.
J Clin Oncol
; 36(8): 735-740, 2018 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369732
12.
Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence.
Sci Rep
; 7: 43813, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28276460
13.
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group.
J Clin Oncol
; 23(30): 7483-90, 2005 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16234514
14.
Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant.
ESMO Open
; 1(4): e000062, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843622
15.
Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis.
Oncotarget
; 6(8): 5634-49, 2015 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25730902
16.
Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.
PLoS One
; 9(7): e101950, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25004125
17.
Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
Eur J Cancer
; 50(8): 1412-21, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24675287
18.
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Mol Oncol
; 8(5): 874-83, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24694649
19.
Detecting Plasma Tumor DNA in Early-Stage Breast Cancer-Letter.
Clin Cancer Res
; 21(15): 3569, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26240292
20.
Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.
Cancer
; 116(9): 2081-9, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20186830